Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
European Respiratory Society
2017
|
| _version_ | 1797076030521868288 |
|---|---|
| author | Pavord, I Kerstjens, H Korn, S Criner, G Sagara, H Rubin, D Harris, S Mayer, B Bradford, E Albers, F Yancey, S |
| author_facet | Pavord, I Kerstjens, H Korn, S Criner, G Sagara, H Rubin, D Harris, S Mayer, B Bradford, E Albers, F Yancey, S |
| author_sort | Pavord, I |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:58:25Z |
| format | Conference item |
| id | oxford-uuid:750cc2ef-96e1-4181-a42d-1c608f033cd6 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:58:25Z |
| publishDate | 2017 |
| publisher | European Respiratory Society |
| record_format | dspace |
| spelling | oxford-uuid:750cc2ef-96e1-4181-a42d-1c608f033cd62022-03-26T20:07:05ZLate breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPDConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:750cc2ef-96e1-4181-a42d-1c608f033cd6Symplectic Elements at OxfordEuropean Respiratory Society2017Pavord, IKerstjens, HKorn, SCriner, GSagara, HRubin, DHarris, SMayer, BBradford, EAlbers, FYancey, S |
| spellingShingle | Pavord, I Kerstjens, H Korn, S Criner, G Sagara, H Rubin, D Harris, S Mayer, B Bradford, E Albers, F Yancey, S Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title | Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title_full | Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title_fullStr | Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title_full_unstemmed | Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title_short | Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD |
| title_sort | late breaking abstract dose ranging study of mepolizumab in eosinophilic copd |
| work_keys_str_mv | AT pavordi latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT kerstjensh latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT korns latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT crinerg latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT sagarah latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT rubind latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT harriss latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT mayerb latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT bradforde latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT albersf latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd AT yanceys latebreakingabstractdoserangingstudyofmepolizumabineosinophiliccopd |